AUSTRALIAN-LED research has brought new hope to patients with cystic fibrosis.
A new drug known as VX-445 when added to existing treatments has demonstrated improved lung function in the studies.
The University of Queensland, Monash University, Alfred Hospital, Mater Hospital and National Jewish Health, USA, collaborated in the study with a follow-up research project supporting the findings.
Visit cysticfibrosis.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Oct 18
